---
title: "Bellevue Life Sciences Acquisition - Unit (BLACU.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/BLACU.US.md"
symbol: "BLACU.US"
name: "Bellevue Life Sciences Acquisition - Unit"
industry: "投資控股公司"
---

# Bellevue Life Sciences Acquisition - Unit (BLACU.US)

| Item | Detail |
|------|--------|
| Industry | 投資控股公司 |

## Company Profile

貝爾維尤生命科學收購公司是一家空白支票公司。公司成立的目的是與一家或多家企業進行合並、換股、資產收購、股票購買、資本重組、重組或類似的業務合並。該公司成立于2020年2月25日，總部設在華盛頓州貝爾維尤。

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -55.83 | - | - | - | - |
| PB | -4.61 | - | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/BLACU.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/BLACU.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/BLACU.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.